uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Lyfnua
Authorised
Human
Details
EMA number
EMEA/H/C/005476
ATC code
R05DB29
Authorisation
15 September 2023
Revision
2
EMA page
Therapeutic indication
Lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.
MeSH:
Cough
Group:
Cough and cold preparations
Special characteristics
Additional monitoring
Active substances
gefapixant
Marketing Authorisation Holder
Merck Sharp & Dohme B.V.
MAH
Timeline
Filter by authority:
EMA
Lyfnua authorised
15 Sept 2023
authorised
regulatory
Lyfnua | uMedical